The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers
Abstract
Purpose In the past decade, there has been an increase in the development and use of oral anti-cancer medications (OAMs), especially for breast cancer-the most prevalent cancer in women. However, adherence rates for OAMs are often suboptimal, leading to lower survival rate, increased risk of recurrence, and higher healthcare costs. Our goal was to identify potentially modifiable psychosocial facilitators and barriers that may be targeted to increase OAM adherence for breast cancer patients.Methods We systematically searched PubMed for studies published in the U.S. by June 15, 2016 that addressed the following: (1) OAMs for breast cancer; (2) medication adherence; and (3) at least one psychosocial aspect of adherence.Results Of the 1752 papers screened, 21 articles were included and analyzed. The most commonly reported motivators for adherence are patient-provider relationships (n = 11 studied, 82% reported significant association) and positive views and beliefs of medication (n = 9 studied, 89% reported significant association). We also identified consistent evidence of the impact of depression and emotions, perception of illness, concern of side effects, self-efficacy in medication management and decision making, knowledge of medication, and social support on OAM adherence.Conclusions Compared to traditional demographic, system, and clinical-related factors that have been well documented in the literature but are not easily changed, these cognitive, psychological, and interpersonal factors are more amendable via intervention and therefore could generate greater benefit in improving patient compliance and health outcomes. As OAMs shift treatment administration responsibility onto patients, continuous provider communication and education on illness and regimen are the keys to supporting patients' medication behavior.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These factors can have negative consequences for the disease course, including an increase in the frequency and duration of hospital stays, lower adherence to treatment recommendations, difficulties in coping with the disease, reduced quality of life and an increase in mortality [9–14].”
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
A new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Patient preferences for oral versus intravenous palliative chemotherapy.
Liu, G., Franssen, E., Fitch, M. I., & Warner, E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.110 · Cited by 917
Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., Kwan, M., Gomez, S. L., & Neugut, A. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1132-4 · Cited by 870
Self-report measures of medication adherence behavior: recommendations on optimal use
Stirratt, M. J., Dunbar-Jacob, J., Crane, H. M., Simoni, J. M., Czajkowski, S., Hilliard, M. E., Aikens, J. E., Hunter, C. M., Velligan, D. I., Huntley, K., et al. (2015) · Translational Behavioral Medicine · doi:10.1007/s13142-015-0315-2 · Cited by 824
Viswanathan, M., Golin, C. E., Jones, C. D., Ashok, M., Blalock, S. J., Wines, R. C. M., Coker-Schwimmer, E. J. L., Rosen, D. L., Sista, P., & Lohr, K. N. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00538 · Cited by 754
Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2114-5 · Cited by 708
Adherence to Therapy With Oral Antineoplastic Agents
Partridge, A. H. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.9.652 · Cited by 585
Patient adherence and persistence with oral anticancer treatment
Ruddy, K., Mayer, E., & Partridge, A. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20004 · Cited by 569
NCCN Task Force Report: Oral Chemotherapy
Weingart, S. N., Brown, E., Bach, P. B., Eng, K. J., Johnson, S. A., Kuzel, T. M., Langbaum, T. S., Leedy, R. D., Muller, R. J., Newcomer, L. N., et al. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.2003 · Cited by 438
Cited by
Sorted by citations
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Riba, M. B., Donovan, K. A., Andersen, B., Braun, I., Breitbart, W. S., Brewer, B. W., Buchmann, L. O., Clark, M. M., Collins, M., Corbett, C., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0048 · Cited by 871
Molecular mechanisms linking exercise to cancer prevention and treatment
Hojman, P., Gehl, J., Christensen, J. F., & Pedersen, B. K. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.015 · Cited by 600
Soundararajan, P., & Kim, J. S. (2018) · Molecules · doi:10.3390/molecules23112983 · Cited by 278
The relationship between acceptance of cancer and distress: A meta-analytic review
Secinti, E., Tometich, D. B., Johns, S. A., & Mosher, C. E. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2019.05.001 · Cited by 132
“and associations with important health outcomes (L. F. Brown et al., 2010; Lin et al., 2017; Pinquart & Duberstein, 2010).”
BackgroundEbrahiminejad, V., Prewett, P. D., Davies, G. J., & Rad, Z. F. (2022) · Advanced Materials Interfaces · doi:10.1002/admi.202101856 · Cited by 81
Zhu, C., Ma, H., He, A., Li, Y., He, C., & Xia, Y. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215814 · Cited by 83
Inotai, A., Ágh, T., van Maris, R. F., Erdősi, D., Kovács, S., Kaló, Z., & Senkus, E. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102264 · Cited by 90
Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review
Rosenberg, S. M., Petrie, K. J., Stanton, A. L., Ngo, L. D., Finnerty, E. K., & Partridge, A. H. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz244 · Cited by 82
Diagnostic and drug release systems based on microneedle arrays in breast cancer therapy
Khan, S., Hasan, A., Attar, F., Babadaei, M. M. N., Zeinabad, H. A., Salehi, M., Alizadeh, M., Hassan, M., Derakhshankhah, H., Hamblin, M. R., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.036 · Cited by 73
Moreno, P. I., Ramírez, A. G., Miguel‐Majors, S. L. S., Castillo, L., Fox, R. S., Gallion, K. J., Muñoz, E., Estabrook, R., Perez, A., Lad, T. E., et al. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4426-4 · Cited by 72
Ekinci, E., Nathoo, S., Korattyil, T., Vadhariya, A., Zaghloul, H. A., Niravath, P. A., Abughosh, S., & Trivedi, M. V. (2018) · Journal of Cancer Survivorship · doi:10.1007/s11764-017-0674-4 · Cited by 68
Blödt, S., Müller‐Nordhorn, J., Seifert, G., & Holmberg, C. (2021) · Health Expectations · doi:10.1111/hex.13171 · Cited by 49
Talens, A., Guilabert, M., Lumbreras, B., Aznar-Saliente, T., & López-Pintor, E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084266 · Cited by 47
Konstantinou, P., Kassianos, A. P., Georgiou, G., Panayides, A., Papageorgiou, A., Almas, I., Wozniak, G., & Karekla, M. (2020) · Translational Behavioral Medicine · doi:10.1093/tbm/ibaa118 · Cited by 89
Park, H. R., Kang, H. S., Kim, S. H., & Singh‐Carlson, S. (2021) · Cancer Nursing · doi:10.1097/ncc.0000000000001030 · Cited by 41
Krok‐Schoen, J. L., Naughton, M. J., Young, G. S., Moon, J., Poi, M. J., Melin, S. A., Wood, M. E., Hopkins, J. O., Paskett, E. D., & Post, D. M. (2019) · Cancer Control · doi:10.1177/1073274819883287 · Cited by 38
Sikorskii, A. E., Given, C. W., Given, B. A., Vachon, E. A., Krauss, J. C., Rosenzweig, M. Q., McCorkle, R. C., Champion, V. L., Banik, A., & Majumder, A. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2018.07.021 · Cited by 35
Lemogne, C., Bellivier, F., Fakra, É., Yon, L., Limosin, F., Consoli, S. M., Lantieri, L. A., & Hivelin, M. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.02.006 · Cited by 32
Gil-Guillén, V. F., Balsa, A., Bernárdez, B., y Llorca, C. V., Contreras, E. M., de la Haba-Rodríguez, J., Castellano, J. M., & Martínez, J. C. G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912036 · Cited by 34
Green, S. M. C., French, D., Graham, C. D., Hall, L., Rousseau, N. S., Foy, R., Clark, J., Parbutt, C., Raine, E., Gardner, B., et al. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08243-4 · Cited by 32
Komatsu, H., Yagasaki, K., Yamaguchi, T., Mori, A., Kawano, H., Minamoto, N., Honma, O., & Tamura, K. (2020) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2020.101780 · Cited by 27
Nguyen, T. Q., Do, M. T., & Pham, T. A. (2021) · Cancer Medicine · doi:10.1002/cam4.4298 · Cited by 27
Factors Associated With Medication Beliefs in Patients With Cancer: An Integrative Review
Marshall, V. K., & Given, B. A. (2018) · Oncology nursing forum · doi:10.1188/18.onf.508-526 · Cited by 26
Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence
Santos, M. D., Lange, M., Gervais, R., Clarisse, B., Capel, A., Barillet, M., Grellard, J., Heutte, N., Licaj, I., & Joly, F. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-4644-4 · Cited by 27
Yu, J., Wu, J., Huang, O., Chen, X., & Shen, K. (2021) · Journal of Medical Internet Research · doi:10.2196/27576 · Cited by 28
Conley, C. C., McIntyre, M., Pensak, N. A., Lynce, F. C., Graham, D. M. A., Ismail-Khan, R. R., Lopez, K., Vadaparampil, S. T., & O’Neill, S. C. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06518-2 · Cited by 27
Omari, M., Zarrouq, B., Amaadour, L., Benbrahim, Z., Asri, A. E., Mellas, N., Rhazi, K. E., Ragala, M. E. A., & Halim, K. (2022) · Cancer Control · doi:10.1177/10732748221074735 · Cited by 28
Racial Comparisons in Timeliness of Colon Cancer Treatment in an Equal-Access Health System
Eaglehouse, Y. L., Georg, M. W., Shriver, C. D., & Zhu, K. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz135 · Cited by 25
Xiang, G., Xing, N., Wang, S., & Zhang, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1172939 · Cited by 24
Schäfer, A., Jírů-Hillmann, S., Widmann, J., Montellano, F. A., Salmen, J., Pryss, R., Wöckel, A., & Heuschmann, P. U. (2025) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01470-6 · Cited by 23
Meneveau, M. O., Keim‐Malpass, J., Camacho, T. F., Anderson, R. T., & Showalter, S. L. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05908-8 · Cited by 21
Moon, Z., Moss-Morris, R. E., Hunter, M. S., & Hughes, L. D. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05850-x · Cited by 23
Poelstra, R., Selles, R. W., Slijper, H. P., van der Oest, M. J. W., Feitz, R., Hovius, S. E. R., Porsius, J. T., & the Hand-Wrist Study Group (2018) · Journal of Hand Surgery (European Volume) · doi:10.1177/1753193418780187 · Cited by 21
Lafata, J. E., Nguyen, B., Staresinic, C., Johnson, M., Gratie, D., & Muluneh, B. (2022) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552211073576 · Cited by 21
Grégoire, C., Marie, N., Sombrun, C., Faymonville, M.-É., Kotsou, I., van Nitsen, V., de Ribaucourt, S., Jérusalem, G., Laureys, S., Vanhaudenhuyse, A., et al. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.807741 · Cited by 23
Nishioka, S., Watanabe, T., Asano, M., YAMAMOTO, T., Kawakami, K., Yada, S., Aramaki, E., Yajima, H., Kizaki, H., & Hori, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267901 · Cited by 21
Tian, X., Tang, L. L., Yi, L.-J., Qin, X.-P., Chen, G., & Herrera, M. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.857659 · Cited by 18
Tian, X., Liao, Z., Yi, L.-J., Tang, L. L., Chen, G., & Herrera, M. (2022) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2022.100151 · Cited by 18
Masiero, M. A., Spada, G. E., Sanchini, V., Munzone, E., Pietrobon, R. S., Teixeira, L., Valencia, M., Machiavelli, A., Fragale, E., Pezzolato, M., et al. (2023) · JMIR Research Protocols · doi:10.2196/48852 · Cited by 17
Le, V. P., Zhong, L., Narsipur, N., Hays, E. A., Tran, D. K., Rosario, K., & Wilson, L. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.3.327 · Cited by 18
Price, G. L., Sudharshan, L., Ryan, P. D., Rajkumar, J., Sheffield, K. M., Smyth, E. N., Guimaraes, C. M., Rybowski, S., Carter, G. C., Gathirua‐Mwangi, W. G., et al. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2073122 · Cited by 18
PVA-PVP-montmorillonite nanocomposite for efficient delivery of doxorubicin to breast cancer cells
Amini, J., Pourmadadi, M., Abedi, M., Yazdian, F. A., Rahdar, A., & Diez-Pascual, A. M. (2024) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2024.112180 · Cited by 16
Çakmak, H. S. G., & Kapucu, S. (2021) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2021.151140 · Cited by 16
Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program
Vacher, L., Thivat, É., Poirier, C., Mouret‐Reynier, M., Chollet, P. J. M., Devaud, H., Dubray‐Longeras, P., Kwiatkowski, F., Durando, X., Praagh-Doreau, I. V., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05144-x · Cited by 15
Labonté, M., Guillaumie, L., Dionne, A. R., Dorval, M., Nabi, H., Lemieux, J., Provencher, L., & Lauzier, S. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.02.004 · Cited by 13
Bentley, S., Morgan, L., Exall, E., Arbuckle, R., Rossom, R. C., Roche, N., Khunti, K. K., Higgins, V., & Piercy, J. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s358046 · Cited by 14
Mortality Prediction of Various Cancer Patients via Relevant Feature Analysis and Machine Learning
Bozkurt, C., & Aşuroğlu, T. (2023) · SN Computer Science · doi:10.1007/s42979-023-01720-5 · Cited by 14
Yang, S., Park, S. W., Bae, S. J., Ahn, S. G., Jeong, J., & Park, K. (2023) · Journal of Breast Cancer · doi:10.4048/jbc.2023.26.e22 · Cited by 16
Yi, F.-C., Zhou, H.-X., Chen, B.-J., Ren, H.-Q., Ma, Z., Zhang, X.-Y., & Duan, J. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15287 · Cited by 12
Boyne, D. J., O'Sullivan, D. E., Heer, E. V., Hilsden, R. J., Sajobi, T. T., Cheung, W. Y., Brenner, D. R., & Friedenreich, C. M. (2020) · Cancer Medicine · doi:10.1002/cam4.2843 · Cited by 11
Factors influencing psychological wellbeing of early breast cancer patients
DeMiglio, L., Murdoch, V., Ivison, J., Fageria, S., & Voutsadakis, I. A. (2020) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2020.09.009 · Cited by 14
Initiatives to Improve Safety of Oral Anticancer Agents Delivered by Community Pharmacists
Fricker, J. (2018) · European Medical Journal · doi:10.33590/emj/10310935 · Cited by 14
Anderson, J. N., Paladino, A. J., Blue, R., Dangerfield, D. T., Eggly, S. S., Martin, M. Y., Schwartzberg, L. S., Vidal, G. A., & Graetz, I. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01511-0 · Cited by 17
Cancer and Stress: Understanding the Connections and Interventions
D’Andre, S. D., Ellsworth, L. L., Kirsch, J. L., Montane, H. N., Kruger, M. B., Donovan, K. A., Bronars, C. A., Markovic, S. N., & Ehlers, S. L. (2024) · American Journal of Lifestyle Medicine · doi:10.1177/15598276241304373 · Cited by 14
Babcock, A., Ali, A. A., Balkrishnan, R., Montero, A. J., & Diaby, V. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.7.826 · Cited by 13
Peerdeman, K. J., Hinnen, C., van Vliet, L. M., & Evers, A. W. M. (2020) · Patient Education and Counseling · doi:10.1016/j.pec.2020.07.021 · Cited by 13
Stephenson, J. J., Gable, J. C., Zincavage, R. M., Price, G. L., Churchill, C., Zhu, E., Stenger, K. B., Singhal, M., Nepal, B., Grabner, M., et al. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s319239 · Cited by 13
Chang, H. A., Barreto, N. B., Davtyan, A., Beier, E., Cangin, M. A., Salman, J., & Patel, S. K. (2019) · Psycho-Oncology · doi:10.1002/pon.5003 · Cited by 12
Pieters, H. C., Green, E., Khakshooy, S., Sleven, M., & Stanton, A. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210972 · Cited by 13
Liao, W.-C., Angus, F., Conley, J., & Chen, L. (2025) · JMIR Cancer · doi:10.2196/64208 · Cited by 16
Dang, T. H., O’Callaghan, C. C., Alexander, M., Burbury, K., Jayaraman, P. P., Wickramasinghe, N. S., & Schofield, P. E. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-08122-6 · Cited by 13
Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy
Tan, E. H., Wong, A. L. A., Tan, C. C., Wong, P., Tan, S. H., Ang, L. E. Y., Lim, S. E., Chong, W. Q., Ho, J., Lee, S. C., et al. (2021) · Journal of Health Psychology · doi:10.1177/1359105321990776 · Cited by 10
Villarreal-Garza, C. M., Mesa-Chávez, F., Ferrigno, A. S., la Garza‐Ramos, C. D., Fonseca, A., Villanueva-Tamez, K., Campos-Salgado, J. Y., Cruz‐Ramos, M., Rodriguez-Gomez, D. O., Ruiz-Cruz, S., et al. (2021) · The Breast · doi:10.1016/j.breast.2021.05.013 · Cited by 10
van Helmondt, S. J., Lodder, P., van Woezik, R., de Vries, J., & van der Lee, M. L. (2023) · Annals of Behavioral Medicine · doi:10.1093/abm/kaac078 · Cited by 10
Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors
Baković, M., Bago, M., Benić, L., Krajinović, M., Silovski, T., Plavetić, N. D., Turković, L., Sertić, M., & Hadžiabdić, M. O. (2023) · Acta Pharmaceutica · doi:10.2478/acph-2023-0045 · Cited by 9
Rinder, P., Marcille, T., Sinel-Boucher, P., Cals-Maurette, M., Kanoun, D., Lévy, C., Teixeira, L., Hornus, P., Szeftel, D., & Heudel, P. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.11909 · Cited by 9
He, P., Zhang, B., & Shen, S. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/9506915 · Cited by 10
Ustaoğlu, G., Bulut, D. G., Üyetürk, Ü., & Uysal, Ö. (2020) · Special Care in Dentistry · doi:10.1111/scd.12538 · Cited by 9
Rzeszutek, M. J., DeFulio, A., & Brown, H. D. (2021) · The Psychological Record · doi:10.1007/s40732-021-00489-4 · Cited by 9
Qi, H., Zhu, L., Chen, L., Zhang, W., Wang, T., Chen, H., Wu, Q., Zhan, Q., Le, T. N., Zhang, L., et al. (2021) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552211027218 · Cited by 8
Saad, A. H., Rabeea, I. S., & Salih, H. (2022) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol30isssuppl.pp31-39 · Cited by 9
Villarreal-Garza, C. M., Ferrigno, A. S., la Garza‐Ramos, C. D., Vazquez‐Juarez, D., Moreno‐Jaime, B., Bonilla, Y. A. R., Segura‐González, M., Mariscal‐Ramírez, I., Perazzo, F., Jaliffe, G. G., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6215 · Cited by 8
Alkan, A., Yaşar, A., Güç, Z. G., Gürbüz, M., Başoğlu, T., Göksu, S. S., Başal, F. B., Türk, H. M., Özdemir, Ö., Çınkır, H. Y., et al. (2020) · European Journal of Cancer Care · doi:10.1111/ecc.13296 · Cited by 8
Vizin, G., Szekeres, T., Juhász, A., Marton, L., Dank, M., Perczel-Forintos, D., & Urbán, R. (2023) · BMC Psychology · doi:10.1186/s40359-023-01355-4 · Cited by 10
Conley, C. C., Wernli, K. J., Knerr, S. A., Li, T., Leppig, K. A., Ehrlich, K. J., Farrell, D., Gao, H., Bowles, E. J. A., Graham, A. L., et al. (2021) · Journal of Cancer Education · doi:10.1007/s13187-021-02114-y · Cited by 7
Anxiety and Depression in Patients with Breast Cancer: A Cross-sectional Study
Podvorica, E., Kraja, J., Rrustemi, N., Dugolli, X., & Hyseni, E. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.8310 · Cited by 7
Adherence to oral hormonal anticancer agents in breast cancer
Gori, S., Modena, A., Foglietta, J., Verzè, M., Inno, A., Casarin, A., Russo, A. D., & Nicolis, F. (2022) · Tumori Journal · doi:10.1177/03008916221096183 · Cited by 7
Sollazzo, F., Nitto, M. D., Rosito, L., Torino, F., Alvaro, R., Lacarbonara, F., Vellone, E., & Durante, Á. (2023) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2023.102327 · Cited by 7
Jayani, R., Hamparsumian, A., Sun, C., Li, D., Chien, L. C., Moreno, J., Katheria, V., Hughes, S. F. D. S., Taylor, W. D., & Dale, W. (2024) · Cancer · doi:10.1002/cncr.35482 · Cited by 7
How do Hematologists Communicate with Patients Suffering from Chronic Lymphocytic Leukemia?
Karamanidou, C., Xochelli, A., Ghia, P., & Σταματόπουλος, Κ. (2021) · European Journal of Health Communication · doi:10.47368/ejhc.2021.306 · Cited by 6
Arch, J. J., Slivjak, E. T., Bright, E. E., Crespi, C. M., Levin, M. E., Genung, S. R., Nealis, M. S., ALBRIGHT, K. J., Mitchell, J. L., Sheth, A. D., et al. (2022) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2022.07.002 · Cited by 6
Bentley, S., Exall, E., Morgan, L., Roche, N., Khunti, K., Rossom, R., Piercy, J., Arbuckle, R., & Higgins, V. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s433662 · Cited by 6
Moysés, R. P. C., Amaral, G. D. S., Viana, J., Benzaken, A. S., & Pereira, M. G. (2021) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2021.1963222 · Cited by 6
Green, S. M. C., French, D., Graham, C. D., Hall, L., Rousseau, N. S., Foy, R., Clark, J., Parbutt, C., Raine, E., Gardner, B., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1239166/v1 · Cited by 6
Sadigh, G., Meisel, J. L., Byers, K., Robles, A., Serrano, L., Jung, O., Coleman, D., Yeager, K. A., & Graetz, I. (2023) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552231161823 · Cited by 5
Baralo, B., Paravathaneni, M., Jain, A., Buragamadagu, B., Khanam, A., Iqbal, S. F., Hossain, S., Mulla, S., Choi, E., & Thirumaran, R. (2022) · BMC Psychology · doi:10.1186/s40359-022-00994-3 · Cited by 5
Koch, E. A. T., Steeb, T., Bender-Säbelkampf, S., Busch, D., Feustel, J., Kaufmann, M. D., Maronna, A., Meder, C. H., Ronicke, M., Toussaint, F., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113813 · Cited by 5
Grégoire, C., Faymonville, M.-É., Vanhaudenhuyse, A., Jérusalem, G., Monseur, J. J., & Bragard, I. (2023) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2023.2249044 · Cited by 7
Green, S. M. C., Smith, S. G., Collins, L. M., & Strayhorn, J. C. (2024) · Translational Behavioral Medicine · doi:10.1093/tbm/ibae029 · Cited by 5
Okroša, A. D., Silovski, T., Plavetić, N. D., Silovski, H., Kovačić, A., & Mucalo, I. (2023) · Acta Pharmaceutica · doi:10.2478/acph-2023-0043 · Cited by 4
Zhang, C., Wang, V., Sarrami, S. M., Reddy, P. D., & Cruz, C. D. L. (2024) · Aesthetic Surgery Journal · doi:10.1093/asj/sjae155 · Cited by 4
Puspitasari, A. W., Kristina, S. A., Satibi, & Prabandari, Y. S. (2022) · INDONESIAN JOURNAL OF PHARMACY · doi:10.22146/ijp.2284 · Cited by 8
Ward, K. A., Muller, D. A., Dutta, S. W., Malhi, J. K., Sanders, J. C., Luminais, C., Millard, T. A., Showalter, T. N., Showalter, S. L., & Janowski, E. (2023) · Clinical Breast Cancer · doi:10.1016/j.clbc.2023.01.012 · Cited by 4
Varet, F., Fournier, V., & Delouvée, S. (2024) · Applied Psychology Health and Well-Being · doi:10.1111/aphw.12615 · Cited by 4
Castel, O. C., Shadmi, E., Keinan‐Boker, L., Granot, T., Karkabi, K., & Dagan, E. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04668-6 · Cited by 4
Schäfer, A., Wendel, J., Franke, I., Bauer, A., Baumeister, H., Bendig, E., Brucker, S. Y., Deutsch, T. M., Garatva, P., Haas, K., et al. (2024) · Trials · doi:10.1186/s13063-024-08614-8 · Cited by 3
“These factors can have negative consequences for the disease course, including an increase in the frequency and duration of hospital stays, lower adherence to treatment recommendations, difficulties in coping with the disease, reduced quality of life and an increase in mortality [9–14].”
de Aguiar, Y. P. M., de Souza, A. E. S., Silva, C. D. L. E., & Queiroz, S. O. D. C. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1417 · Cited by 3
Nishioka, S., Asano, M., Yada, S., Aramaki, E., Yajima, H., Yanagisawa, Y., Sayama, K., Kizaki, H., & Hori, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-42496-1 · Cited by 5
Oral Anticancer Therapies: Addressing Nonadherence in Patients With Breast Cancer
Cazzaniga, M. E., Huober, J., Tamma, A. V., Emde, A., Thoele, K., & O’Shaughnessy, J. (2024) · Clinical Breast Cancer · doi:10.1016/j.clbc.2024.12.011 · Cited by 4
Paladino, A. J., Pebley, K., Kocak, M., Krukowski, R. A., Waters, T. M., Vidal, G. A., Schwartzberg, L. S., Curry, A. N., & Graetz, I. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08705-9 · Cited by 3
Metadata
- Authors
- Lin, C., Clark, R., Tu, P., Bosworth, H. B., & Zullig, L. L.
- Affiliations
- Duke University (US)
- Corresponding author
- Lin, Cheryl
- Venue
- Breast Cancer Research and Treatment
- Published
- 2017-06-01
- Volume
- 165
- Issue
- 2
- Pages
- 247-260
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W2621337730
- Cited by
- 160
- References
- 55
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 20 · 2023: 22 · 2022: 32 · 2021: 23 · 2020: 14 · 2019: 12 · 2018: 7 · 2017: 1
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Breast Cancer Research and Treatment (publishedVersion)
- PubMed (publishedVersion)
- Funders
- VA Research Career Scientist Award (RCS 08-027)
- VA Health Services Research and Development (HSR&D) Career Development Award (CDA 13-025)
- Duke University Bass Connections
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
- Keywords
- breast cancer, medication adherence, psychosocial factors, patient-provider relationship, medication beliefs, depression, adverse effects, self-efficacy, social support, patient education, treatment adherence interventions
- MeSH terms
- Administration, Oral, Antineoplastic Agents, Breast Neoplasms, Female, Humans, Physician-Patient Relations, Quality of Life, Stress, Psychological, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review